Press release
Liposome Market to Reach USD 17.1 Billion by 2034, Driven by a 7% CAGR
Market Development
Innovations in liposomal drug formulations, increased research collaborations, and expanding pharmaceutical applications are propelling market growth. The demand for formulated liposomes, particularly in oncology and infectious disease treatment, is surging. Governments in regions such as China and Japan are supporting liposome-based drug development, further stimulating the market.
For More Insights into the Market, Request a Sample of this Report:https://www.factmr.com/connectus/sample?flag=S&rep_id=9589
Market Outlook
The future of the liposome market looks promising, with key players focusing on enhancing bioavailability, reducing toxicity, and improving drug stability. The rise in personalized medicine and nanotechnology-driven drug delivery systems will continue to drive growth. North America and East Asia are expected to be the dominant markets, with China witnessing the fastest CAGR of 9.7%.
Market Analysis
Product Type: Formulated liposomes dominate the market, accounting for 69.5% of total demand in 2024. Their applications in cancer treatment are driving this growth.
Application: Drug delivery remains the largest segment, holding 91.2% of market share in 2024, with an estimated CAGR of 7.1% by 2034. The use of liposomes in contrast imaging is also rising.
Regional Analysis: North America leads the market, with a revenue projection of US$3,318 million in 2024. The United States holds 88.1% of this market. China is set for rapid growth due to government initiatives in pharmaceutical research.
Market Segmentation
By Product Type
Simple Liposomes
Formulated Liposomes (Doxorubicin, Amphotericin B, Paclitaxel, Cisplatin, and others)
Vaccines
By Application
Drug Delivery (Cancer, Fungal Infections, Viral & Parasitic Infections)
Gene Delivery or Transfection
Contrast Agents for Medical Imaging
Key Players Covered in This Report
The liposome market is highly consolidated, with key players controlling over 50% of market demand. Notable companies include:
Novartis AG (Liposoma BV)
Gilead Sciences, Inc.
Johnson & Johnson (Janssen Pharmaceutical Companies)
Pacira BioSciences, Inc.
Fujifilm Holdings Corporation
Sun Pharma Industries Ltd.
Taiwan Liposome Company Ltd.
Jazz Pharmaceuticals plc
Ipsen Biopharmaceuticals, Inc.
Competitive Landscape
Leading firms are investing in R&D collaborations to expand their product portfolios. Some recent developments include:
Endo International PLC partnered with Taiwan Liposome Company in June 2022 to develop TLC599, a drug for osteoarthritis pain relief.
Sun Pharma Advanced Research Company introduced a liposome-encapsulated paclitaxel formulation for breast cancer treatment in January 2022.
Get Customization on this Report for Specific Research Solutions-https://www.factmr.com/connectus/sample?flag=S&rep_id=9589
Highlights of Our Report
Comprehensive Market Analysis covering growth projections, trends, and key challenges.
Detailed Market Segmentation to identify high-growth areas.
Competitive Landscape Overview, featuring key players, strategies, and partnerships.
Regional Insights highlighting growth potential across North America, East Asia, and Europe.
Key Opportunities in oncology drug delivery, personalized medicine, and contrast imaging.
Key Opportunities
Increasing cancer prevalence is driving demand for liposomal chemotherapy drugs.
Growing adoption of nanotechnology in pharmaceuticals is enhancing liposomal stability and efficacy.
Expanding R&D investments in liposomal formulations are opening new market avenues.
Questions Answered by the Report
What are the key drivers of the liposome market?
Which regions are expected to lead in market growth?
Who are the leading players in the market?
What are the future growth opportunities?
How is the market segmented by product type and application?
This detailed report by Fact.MR provides a thorough analysis of the liposome market, equipping businesses with data-driven insights to make informed decisions.
Explore More Related Studies Published by Fact.MR Research:
Esophageal Stents Market
https://www.factmr.com/report/esophageal-stents-market
Dyslipidemia Therapeutics Market
https://www.factmr.com/report/2928/dyslipidemia-therapeutics-market
Thymus Cancer Treatment Market
https://www.factmr.com/report/thymus-cancer-treatment-market
Disposable Intestinal Wash Bags Market
https://www.factmr.com/report/disposable-intestinal-wash-bags-market
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com
About Fact.MR:
We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Liposome Market to Reach USD 17.1 Billion by 2034, Driven by a 7% CAGR here
News-ID: 3954504 • Views: …
More Releases from FactMR
Vascular Grafts Market Valued at USD 4.23 Billion in 2025 | Medtronic PLC, Cook …
The global vascular grafts market is estimated at US$ 3.73 billion in 2023 and is predicted to climb to a value of US$ 7.04 billion by the end of 2033. As per this detailed Fact.MR research analysis, worldwide demand for vascular grafts is forecasted to rise at a healthy 6.5% CAGR over the next ten years.This robust growth is driven by the surging prevalence of cardiovascular disorders, chronic renal diseases,…
Neurorehabilitation Devices Market to Hit USD 2 Billion by 2025 | Medtronic, Bos …
The global neurorehabilitation devices market size is valued at US$ 1.48 billion in 2023 and is forecasted to surge to a size of US$ 5.4 billion by 2033-end. Worldwide neurorehabilitation system sales are projected to rise at an astronomical 13.8% CAGR over the next ten years.This impressive growth is fueled by the rising prevalence of neurological disorders, an aging global population, advancements in wearable and robotic technologies, and increasing demand…
Spectrometry Market to Hit USD 37.55 Billion by 2033 | Thermo Fisher Scientific, …
The global spectrometry market size accounts for a valuation of US$ 18.75 billion in 2023 and is forecasted to climb to US$ 37.55 billion by the end of 2033. As per this detailed Fact.MR research analysis, worldwide demand for spectrometry is predicted to rise at 7.1% CAGR over the next ten years.This robust growth is driven by increasing investments in research and development (R&D), advancements in spectrometry technologies, expanding applications…
Softgel Capsules Market to Reach USD 2.16 Billion by 2033 | Catalent, Aenova, Fu …
The global softgel capsules market size stands at US$ 1.17 billion in 2023. As per the recently published research report by Fact.MR, worldwide sales of softgel capsules are predicted to rise at a CAGR of 6.3% and reach US$ 2.16 billion by 2033-end. This growth is fueled by the increasing demand for softgel capsules in the pharmaceutical and healthcare sectors, driven by their versatile applications in treating cardiovascular, inflammatory, and…
More Releases for Liposome
Irinotecan Hydrochloride Liposome Injection Market Forecast to 2034
Market Overview
As of 2024, the Irinotecan Hydrochloride Liposome Injection Market is valued at USD 116 million. It is expected to grow at a Compound Annual Growth Rate (CAGR) of 10.1% from 2024 to 2034, reaching approximately USD 305 million by 2034.
Download Full PDF Sample Copy of Market Report @
https://exactitudeconsultancy.com/request-sample/59123
Key Market Highlights:
• Base Year: 2023
• Forecast Period: 2024-2034
• 2024 Market Size: USD 116 Million
• 2034 Forecasted Size: USD 305 Million
• CAGR: 10.1%
• Primary Driver: Rising prevalence of…
Doxorubicin Hydrochloride Liposome Injection Market Size, Share and Growth Repor …
" The global market for Doxorubicin Hydrochloride Liposome Injection is projected to reach approximately $1.2 billion in 2024. The forecast period from 2025 to 2034 is expected to witness significant expansion, with a projected market value increasing to around $2.5 billion by 2034. This growth represents a Compound Annual Growth Rate (CAGR) of approximately 8.1% during the forecast period, driven by rising incidences of various cancers, advancements in liposomal drug…
Liposome Drug Delivery Market Future Prediction Report By 2031
A new market study report by The Insight Partners on the Liposome Drug Delivery Market has been released with reliable information and accurate forecasts for a better understanding of the current and future market scenarios. The report offers an in-depth analysis of the global market, including qualitative and quantitative insights, historical data, and estimated projections about the market size and share in the forecast period.
Get PDF Sample Report…
Liposome Makeover: How Creative Biolabs is Amping Up Drug Delivery
Creative Biolabs is at the forefront of the liposome "revolution", offering cutting-edge liposome development services tailored to meet the complex needs of researchers and pharmaceutical companies.
New York, USA - September 11, 2024 - As the biotech and pharmaceutical sectors continue their rapid evolution, the demand for innovative and efficient drug delivery systems has reached an all-time high. One of the most promising developments in this field has been the use…
Turkey Liposome Drug Delivery Market Trends and Growth Factors Analysis
The global liposome drug delivery market is estimated to attain a valuation of ~US$ 8 Bn by the end of 2027, states a study by Transparency Market Research (TMR). Besides, the report notes that the market is prognosticated to expand at a CAGR of ~9% during the forecast period, 2019 to 2027.
The key objective of the TMR report is to offer a complete assessment of the global market including major…
Liposome in Cosmetics Market Size, Share, Development by 2023
New report published by Market Research Report Store (MRRS) which offers insights on the global Liposome in Cosmetics market.
Liposomes are spherical vesicles in which their central aqueous section is surrounded by one or more of a bilayer membrane (Lamella) that is frequently enclosed by aquatic environments. These vesicles are formed when amphiphilic lipids confront with aqueous milieu. They can vary in size from 15 nm to several microns. In the…
